Alzheimer Disease Screening Profile CSF
Overview of Alzheimer Disease Screening Profile CSF in Kannur
The Alzheimer Disease Screening Profile, CSF is a specialized diagnostic panel that measures key cerebrospinal fluid (CSF) biomarkers associated with Alzheimer’s disease. The profile includes Total Tau, Beta Amyloid (1-42), Beta Amyloid (1-40), and the Beta Amyloid (1-42/1-40) Ratio. These biomarkers help evaluate the biological changes linked to Alzheimer’s disease and support the assessment of individuals with memory impairment or cognitive decline. The test is used alongside clinical evaluation, neurological examination, brain imaging, and other diagnostic investigations to provide a more comprehensive understanding of cognitive disorders.
Who should get this test done?
This test may be recommended for individuals who:
● Have persistent memory loss or progressive cognitive decline.
● Show symptoms suggestive of Alzheimer’s disease or other neurodegenerative disorders.
● Require further evaluation when the cause of dementia is uncertain.
● Need biomarker assessment to support the diagnosis of cognitive disorders.
● Are advised by a neurologist as part of a comprehensive dementia evaluation.
Why consider this test?
Memory problems can arise from several neurological conditions, and distinguishing Alzheimer’s disease from other causes is often challenging. The Alzheimer Disease Screening Profile evaluates a combination of CSF biomarkers that reflect changes occurring in the brain. Assessing these markers together provides valuable information that complements clinical findings and imaging studies, helping healthcare providers make a more informed diagnosis and plan appropriate management for individuals with cognitive impairment.
More information
This profile analyzes Total Tau, Beta Amyloid (1-42), Beta Amyloid (1-40), and the Beta Amyloid (1-42/1-40) ratio, all of which are established biomarkers used in the evaluation of Alzheimer’s disease. The test is performed on a cerebrospinal fluid (CSF) sample obtained through a lumbar puncture. It is particularly useful when additional laboratory evidence is needed to support the assessment of cognitive decline and should always be interpreted in conjunction with the individual’s symptoms, neurological examination, neuropsychological assessment, and imaging findings.
Other names
● Alzheimer’s Disease CSF Biomarker Panel
● CSF Alzheimer’s Biomarker Profile
● Alzheimer’s Disease Screening Panel, CSF
● CSF Tau and Beta Amyloid Profile
● Alzheimer’s Disease CSF Marker Test
Test included
- Csf, Total Tau
- Csf, Beta Amyloid (1-42)
- Csf, Beta Amyloid (1-40)
- Csf, Beta Amyloid Ratio(1-42/1-40)
Doctor information
Test code
10579
CPT and Loinc codes
Department
- Local Send Out
Turn around time
10 Working Days
Test run frequency
Every Day TIME - 09:00
Performing locations
1 labs across India
Specimen vol. and vacutainer information
| Specimen | Vacutainer | Volume |
|---|---|---|
| Csf | Plain Sterile Vaccutainer | 2 |
Specimen stability information
Csf
Test price
₹16275
Need Help?
Talk to our health experts for guidance on tests, reports, or bookings.
WhatsApp to Book TestAlzheimer Disease Screening Profile CSF
₹16275